Testing Ultimaster stents in everyday patient care
Part of Heart & circulation clinical trials.
This trial looks at how safe and effective two specific stents are when doctors use them as part of routine care. You may be a candidate if you’re an adult receiving one of these Ultimaster stents and can follow the study check-in schedule.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 19 years old
- Be getting an Ultimaster Tansei stent and/or an Ultimaster Nagomi stent
- Agree to the study plan and attend required follow-up visits
- Sign informed consent (you or your guardian)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests a new long stent (Ultimaster Nagomi) for treating long blockages in the heart arteries. It aims to see how well the stent works in real-world patients who need a single stent for a long lesion.
This study checks how safe and effective two types of heart stents (Synergy XD and Synergy Megatron) are after they are placed. You might consider it if you’re an adult getting one of these stents and can follow required clinic visits.
This study tracks how well a newer heart stent (a small metal tube that keeps arteries open) works in real patients. Researchers want to understand if this specific stent design is safe and effective over time.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.